iRhythm Technologies (IRTC) Expected to Announce Quarterly Earnings on Thursday

iRhythm Technologies (NASDAQ:IRTC) will likely be posting its Q3 2025 results after the market closes on Thursday, October 30th. Analysts expect iRhythm Technologies to post earnings of ($0.36) per share and revenue of $184.7460 million for the quarter. iRhythm Technologies has set its FY 2025 guidance at EPS.Investors may review the information on the company’s upcoming Q3 2025 earningreport for the latest details on the call scheduled for Thursday, October 30, 2025 at 4:30 PM ET.

iRhythm Technologies (NASDAQ:IRTC) last released its quarterly earnings results on Thursday, July 31st. The company reported ($0.32) EPS for the quarter, topping analysts’ consensus estimates of ($0.53) by $0.21. iRhythm Technologies had a negative return on equity of 90.03% and a negative net margin of 14.06%.The company had revenue of $186.69 million for the quarter, compared to analysts’ expectations of $173.94 million. During the same period in the prior year, the firm earned ($0.61) earnings per share. The firm’s revenue was up 26.1% compared to the same quarter last year. On average, analysts expect iRhythm Technologies to post $-2 EPS for the current fiscal year and $-1 EPS for the next fiscal year.

iRhythm Technologies Stock Down 0.0%

iRhythm Technologies stock opened at $182.67 on Wednesday. iRhythm Technologies has a twelve month low of $67.92 and a twelve month high of $188.53. The stock’s fifty day simple moving average is $175.87 and its 200-day simple moving average is $151.23. The company has a current ratio of 5.02, a quick ratio of 4.88 and a debt-to-equity ratio of 6.25. The firm has a market capitalization of $5.87 billion, a P/E ratio of -62.34 and a beta of 1.15.

Wall Street Analysts Forecast Growth

IRTC has been the topic of several recent analyst reports. BTIG Research increased their target price on iRhythm Technologies from $190.00 to $195.00 and gave the company a “buy” rating in a report on Monday, October 13th. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of iRhythm Technologies in a report on Wednesday, October 8th. William Blair raised shares of iRhythm Technologies to a “strong-buy” rating in a report on Friday, August 1st. JPMorgan Chase & Co. increased their target price on shares of iRhythm Technologies from $145.00 to $190.00 and gave the company an “overweight” rating in a report on Friday, August 1st. Finally, Bank of America initiated coverage on shares of iRhythm Technologies in a research note on Wednesday, August 20th. They set a “buy” rating and a $200.00 price objective for the company. One investment analyst has rated the stock with a Strong Buy rating, eleven have given a Buy rating, two have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $184.85.

Insider Buying and Selling at iRhythm Technologies

In related news, insider Chad Patterson sold 2,707 shares of iRhythm Technologies stock in a transaction on Monday, August 4th. The shares were sold at an average price of $164.36, for a total transaction of $444,922.52. Following the transaction, the insider owned 46,222 shares in the company, valued at approximately $7,597,047.92. The trade was a 5.53% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Abhijit Y. Talwalkar sold 5,312 shares of the business’s stock in a transaction on Monday, August 11th. The stock was sold at an average price of $158.02, for a total transaction of $839,402.24. Following the completion of the transaction, the director owned 20,299 shares in the company, valued at $3,207,647.98. This represents a 20.74% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last three months, insiders have sold 47,069 shares of company stock worth $7,627,986. Corporate insiders own 0.68% of the company’s stock.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently bought and sold shares of the company. Lazard Asset Management LLC bought a new stake in iRhythm Technologies during the second quarter worth approximately $72,000. Strs Ohio purchased a new stake in shares of iRhythm Technologies in the 1st quarter valued at approximately $147,000. State of Wyoming purchased a new stake in shares of iRhythm Technologies in the 2nd quarter valued at approximately $179,000. Canada Pension Plan Investment Board lifted its position in shares of iRhythm Technologies by 833.3% in the 2nd quarter. Canada Pension Plan Investment Board now owns 2,800 shares of the company’s stock valued at $431,000 after acquiring an additional 2,500 shares in the last quarter. Finally, Tower Research Capital LLC TRC lifted its position in shares of iRhythm Technologies by 296.5% in the 2nd quarter. Tower Research Capital LLC TRC now owns 3,842 shares of the company’s stock valued at $592,000 after acquiring an additional 2,873 shares in the last quarter.

About iRhythm Technologies

iRhythm Technologies, Inc, a digital healthcare company, engages in the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. It offers Zio services, an ambulatory monitoring solution, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services.